Ophthalmic composition
AssigneeSanten SAS
InventorsTimo Reunamaki, Kari Lehmussaari, Eija Vartiainen, Olli Oksala, Sakari Alaranta
Life of this patent
Estimating the term…
Loading patent…
AssigneeSanten SAS
InventorsTimo Reunamaki, Kari Lehmussaari, Eija Vartiainen, Olli Oksala, Sakari Alaranta
Estimating the term…
The present invention is directed to an ophthalmic composition in the form of a topical aqueous solution consisting essentially of an ophthalmologically active agent, an ion sensitive, hydrophilic polymer in an amount a of 0.004 to 1.5% by weight, at least one salt selected from the group of inor ganic salts and buffers in a total amount of from 0.01 to 2.0% by weight, a wetting agent in an amount of 0 to 3.0% by weight, a preservative in an amount of 0 to 0.02% by weight, water, and optionally a pH regulating agent in an amount sufficient to give a pH of 4.0 to 8.0 to the composition, the ratio between salt and polymer components being such that the solution exhibits a viscosity of less than 1000 mPas. The composition contains a sufficient amount of polymer to provide for a controlled absorption of the drug into the eye, its viscosity having been reduced to provide for better handling characteristics.
Ophthalmic composition in the form of a topical aqueous solution consisting essentially of
Dependencies are inferred from the claim text.